CORPORATE SPONSOR
Ubiquitin Drug Discovery and Diagnostics 2009 (ARCHIVE)
Date: October 13, 2009 — October 14, 2009
Location: Park Hyatt at the Bellevue (Philadelphia)
CORPORATE SPONSOR DETAILS
Click to Download BrochureCORPORATE SPONSORS
Cephalon Oncology
Cephalon Oncology research is focused on understanding and directing the molecular mechanisms of cell survival. By uncovering the cell signaling pathways that command a cell to survive and divide — or, conversely, to die — Cephalon Oncology is preparing the way for novel therapeutics.
Going further inside the cell
Researchers at Cephalon Oncology use their technical expertise in molecular biology, molecular and behavioral pharmacology, biochemistry, cell biology, tumor biology and chemistry to develop new medicines.
Cephalon Oncology scientists look deep inside the cell to understand what biochemical mechanisms play a role in cell survival and cell death. With research in cell signaling pathways, kinase inhibition, apoptosis and angiogenesis, the company is committed not only to identifying novel pathways for regulation of cell survival and death, but also to exploiting inhibitors or activators of these pathways for therapeutic use against human disease.
Millennium Pharmaceuticals Inc.
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company. We are focused exclusively in oncology to improve the treatment of cancer around the world.
GlaxoSmithKline Oncology
Oncology is GSK's most dynamic field. Their firm foundation in science and dedication to research have led to a robust portfolio of products for the reduction in risk and treatment of cancer, as well as patient support. Their commitment to advancing knowledge in this field is best illustrated by the decades-long partnership of Nobel laureates Gertrude Elion and Dr George Hitchings, whose work resulted in new therapeutics to improve the lives of cancer patients. Their findings led to the development of drugs that block nucleic acid synthesis in cancer cells, and resulted in the 1988 Nobel Prize in Physiology or Medicine.
Duane Morris LLP
Duane Morris LLP, a full-service law firm with more than 700 attorneys in 24 offices in the United States and internationally, offers innovative solutions to the legal and business challenges presented by today's evolving global markets.
LifeSensors Inc.
LifeSensors is a company that sets out to develop and market innovative SUMO and ubiquitin centric products for therapeutic, diagnostic and research markets. The company partners with and provides services to companies and institutions with the aim of reducing the cost and improving the quality of desired protein production.
Progenra Inc.
Progenra, Inc. is dedicated to finding new medicines for a variety of diseases through the ubiquitin pathway, a critical mechanism of cellular regulation. Progenra's assay platform and unique profiling capacity can identify selective inhibitors of critical ubiquitin pathway enzymes associated with cancer, osteoporosis, and other debilitating diseases. This technology and multiple selective compounds are available for licensing.
